Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto D'Angelo

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
International Reviews of Immunology|June 18, 2020
Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer: a systematic review and meta-analysis of preclinical studiesMaryam Sahlolbei, Mohsen Dehghani, Behghat Kheiri Yeghane Azar, et al.
Cells|July 18, 2018
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast CancerNavid Sobhani, Anna Ianza, Alberto D'Angelo, et al.
Cells|April 10, 2019
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast CancerNavid Sobhani, Alberto D'Angelo, Matteo Pittacolo, et al.
Critical Reviews in Oncology/Hematology|March 23, 2021
Maintenance in gastric cancer: New life for an old issue?Giandomenico Roviello, Maria Grazia Rodriquenz, Giuseppe Aprile, et al.
Diseases (Basel, Switzerland)|March 27, 2024
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature ReviewSimona Laurino, Sabino Russi, Ludmila Carmen Omer, et al.
Journal of Clinical Medicine|November 5, 2020
Methylene Blue-Current Knowledge, Fluorescent Properties, and Its Future UseTomasz Cwalinski, Wojciech Polom, Luigi Marano, et al.
Cancers|November 11, 2020
Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted TherapiesAlberto D'Angelo, Navid Sobhani, Robert Chapman, et al.
Anti-Cancer Drugs|February 4, 2020
Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancerGiandomenico Roviello, Raffaele Conca, Alberto D'Angelo, et al.
Current Cancer Drug Targets|September 22, 2020
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA StudyMartina Catalano, Giandomenico Roviello, Raffaele Conca, et al.
Plos One|August 6, 2019
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinomaAlberto D'Angelo, Navid Sobhani, Giandomenico Roviello, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
International Reviews of Immunology|June 18, 2020
Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer: a systematic review and meta-analysis of preclinical studiesMaryam Sahlolbei, Mohsen Dehghani, Behghat Kheiri Yeghane Azar, et al.
Cells|July 18, 2018
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast CancerNavid Sobhani, Anna Ianza, Alberto D'Angelo, et al.
Cells|April 10, 2019
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast CancerNavid Sobhani, Alberto D'Angelo, Matteo Pittacolo, et al.
Critical Reviews in Oncology/Hematology|March 23, 2021
Maintenance in gastric cancer: New life for an old issue?Giandomenico Roviello, Maria Grazia Rodriquenz, Giuseppe Aprile, et al.
Diseases (Basel, Switzerland)|March 27, 2024
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature ReviewSimona Laurino, Sabino Russi, Ludmila Carmen Omer, et al.
Journal of Clinical Medicine|November 5, 2020
Methylene Blue-Current Knowledge, Fluorescent Properties, and Its Future UseTomasz Cwalinski, Wojciech Polom, Luigi Marano, et al.
Cancers|November 11, 2020
Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted TherapiesAlberto D'Angelo, Navid Sobhani, Robert Chapman, et al.
Anti-Cancer Drugs|February 4, 2020
Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancerGiandomenico Roviello, Raffaele Conca, Alberto D'Angelo, et al.
Current Cancer Drug Targets|September 22, 2020
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA StudyMartina Catalano, Giandomenico Roviello, Raffaele Conca, et al.
Plos One|August 6, 2019
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinomaAlberto D'Angelo, Navid Sobhani, Giandomenico Roviello, et al.
Pageof 6